The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
However, you come and give these women estrogen, what happens? You can stimulate these endometriosis implants all over again. And this is what happens. So, endometriosis patients in general have a slightly higher increased risk of ovarian cancer, especially the ones with endometrias or advanced disease. Post-menopause hormone replacement, the estrogen, can still stimulate these implants.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
In patients with endometriosis, even when they undergo a hyerectomy and they're using estrogen patches, you always want to give them the progesterone because otherwise you stimulate this these implants again because of unopposed estrogen.